869102-86-3

Upstream product

• 103233-24-5 (2R,4S)-4-<<(tert-butyldiphenylsilyl)oxy>methyl>-2-methyl-4-butanolide 
• 869102-84-1 (2S,4R)-1-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-hex-5-yn-2-ol 
• 869102-85-2 (2S,4R)-2-(4-Methoxy-benzyloxy)-4-methyl-hex-5-yn-1-ol 
• 869102-83-0 (2S,4R)-2-(4-Methoxy-benzyloxy)-4-methyl-hex-5-ynoic acid 
• 851626-19-2 (2S,3E)-5-(tert-butyl(diphenyl)silyloxy)-4-methylpent-3-en-2-ol 

Downstream Products

• 869102-82-9 (R)-2-(4-Methoxy-benzyloxy)-4-methyl-6-trimethylsilanyl-hex-5-ynoic acid (E)-(S)-4-(tert-butyl-diphenyl-silanyloxy)-1,3-dimethyl-but-2-enyl ester 

Relevant academic research and scientific papers

Diastereoselective access to the spirotetronate subunit of the quartromicins

The agalacto-spirotetronate B subunit of quartromicins was synthesized in a predictible manner, following the Claisen-Ireland/metathesis approach (CIM strategy). Ene-yne ring-closure and selective mismatch Sharpless dihydroxylation are discussed as key st